行情

DPLO

DPLO

Diplomat
NYSE

实时行情|Nasdaq Last Sale

5.61
-0.01
-0.18%
盘后: 5.61 0 0.00% 16:07 09/17 EDT
开盘
5.60
昨收
5.62
最高
5.84
最低
5.55
成交量
61.89万
成交额
--
52周最高
21.48
52周最低
4.170
市值
4.25亿
市盈率(TTM)
-0.8845
分时
5日
1月
3月
1年
5年

分析师评级

12位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DPLO 新闻

  • Benzinga's Top Upgrades, Downgrades For September 12, 2019
  • Benzinga.5天前
  • Deutsche Bank likes CVS Health, sees 42% upside
  • Seeking Alpha - Article.5天前
  • Health-Care Stocks Are Worth a Look Despite Risk of Price Regulation, Analyst Says
  • marketwatch.com.5天前
  • Deutsche Bank Initiates Coverage On Diplomat Pharmacy with Sell Rating, Announces $4 Price Target
  • Benzinga.5天前

更多

所属板块

医疗设施与服务
-0.69%
医疗保健提供商与服务
-0.93%

热门股票

名称
价格
涨跌幅

DPLO 简况

Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company's primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company's patient care system is used to coordinate and track patient adherence and safety.
展开

Webull提供Diplomat Pharmacy Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。